Skip to main content

Showing 1–5 of 5 results for author: Waites, L H

.
  1. arXiv:2306.16607  [pdf, other

    physics.ins-det

    The EPICS control system for IsoDAR

    Authors: Philip Weigel, Monica Busza, Abutalib Namazov, Janette Park, Joshua Villarreal, Loyd H. Waites, Daniel Winklehner

    Abstract: Many large accelerator facilities have adopted the open-source EPICS software as the quasi-industry standard for control systems. They typically have access to their own electronics laboratory and dedicated personnel for control system development. On the other hand, small laboratories, many based at universities, use commercial software like LabView, or entirely homebrewed systems. These often be… ▽ More

    Submitted 2 August, 2023; v1 submitted 28 June, 2023; originally announced June 2023.

  2. arXiv:2201.10040  [pdf, other

    physics.ins-det hep-ex

    IsoDAR@Yemilab: A Report on the Technology, Capabilities, and Deployment

    Authors: Jose R. Alonso, Daniel Winklehner, Joshua Spitz, Janet M. Conrad, Seon-Hee Seo, Yeongduk Kim, Michael Shaevitz, Adriana Bungau, Roger Barlow, Luciano Calabretta, Andreas Adelmann, Daniel Mishins, Larry Bartoszek, Loyd H. Waites, Ki-Mun Bang, Kang-Soon Park, Erik A. Voirin

    Abstract: IsoDAR@Yemilab is a novel isotope-decay-at-rest experiment that has preliminary approval to run at the Yemi underground laboratory (Yemilab) in Jeongseon-gun, South Korea. In this technical report, we describe in detail the considerations for installing this compact particle accelerator and neutrino target system at the Yemilab underground facility. Specifically, we describe the caverns being prep… ▽ More

    Submitted 11 July, 2022; v1 submitted 24 January, 2022; originally announced January 2022.

    Comments: Under review at JINST. Condensed article version of full Conceptual Design Report (arXiv:2110.10635)

  3. arXiv:2110.10635  [pdf, other

    physics.ins-det hep-ex

    IsoDAR@Yemilab: A Conceptual Design Report for the Deployment of the Isotope Decay-At-Rest Experiment in Korea's New Underground Laboratory, Yemilab

    Authors: J. R. Alonso, K. M. Bang, R. Barlow, L. Bartoszek, A. Bungau, L. Calabretta, J. M. Conrad, S. Kayser, Y. D. Kim, K. S. Park, S. H. Seo, M. H. Shaevitz, J. Spitz, L. H. Waites, D. Winklehner

    Abstract: This Conceptual Design Report addresses the site-specific issues associated with the deployment of the IsoDAR experiment at the Yemilab site. IsoDAR@Yemilab pairs the IsoDAR cyclotron-driven $\barĪ½_e$ source with the proposed Liquid Scintillator Counter (LSC) 2.5 kton detector. This document describes the proposed siting: requirements for the caverns to house the cyclotron, beam transport line, an… ▽ More

    Submitted 28 December, 2021; v1 submitted 20 October, 2021; originally announced October 2021.

  4. arXiv:2003.07931  [pdf

    physics.acc-ph

    Medical Isotope Production with the IsoDAR Cyclotron

    Authors: Jose R. Alonso, Roger Barlow, Janet M. Conrad, Loyd Hoyt Waites

    Abstract: Authors describe technical advances that will allow the IsoDAR cyclotron -- being developed for neutrino physics research -- to produce medical isotopes more efficiently than existing cyclotrons can.

    Submitted 19 March, 2020; v1 submitted 17 March, 2020; originally announced March 2020.

    Comments: 3 pages 1 table

    Journal ref: www.nature.com/natrevphys, Volume 1 pages 533-535, September 2019

  5. arXiv:1807.06627  [pdf

    physics.acc-ph physics.ins-det physics.med-ph

    What is the Potential Impact of the IsoDAR Cyclotron on Radioisotope Production: A Review

    Authors: Loyd Hoyt Waites, Jose R Alonso, Roger Barlow, Janet Conrad

    Abstract: The IsoDAR collaboration is develo** a high-current cyclotron for a neutrino search experiment. Designed to deliver 10 mA of 60 MeV protons, the current and power of this cyclotron far exceed those of existing accelerators, opening new possibilities for the production of radiopharmaceutical isotopes, producing very high-activity samples in very short times. The cyclotron can also be easily confi… ▽ More

    Submitted 19 March, 2020; v1 submitted 17 July, 2018; originally announced July 2018.

    Comments: 23 pages, 7 figures, manuscript submitted to European Journal of Nuclear Medicine

    Journal ref: EJNMMI Radiopharmacy and Chemistry 5:6 (2020)